Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammatory Bowel Disease Therapeutics: A Focus on Probiotic Engineering
Jayshree Mishra, Madyson Stubbs, Longxiang Kuang, et al.
Mediators of Inflammation (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives
Supriya Roy, Suneela Dhaneshwar
World Journal of Gastroenterology (2023) Vol. 29, Iss. 14, pp. 2078-2100
Open Access | Times Cited: 136
Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: A review
Min’an Zhao, Jiayi Chu, Shiyao Feng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114985-114985
Open Access | Times Cited: 115
Multidrug Resistance of Cancer Cells and the Vital Role of P-Glycoprotein
Chenmala Karthika, R. Sureshkumar, Mehrukh Zehravi, et al.
Life (2022) Vol. 12, Iss. 6, pp. 897-897
Open Access | Times Cited: 79
Roles of Short-Chain Fatty Acids in Inflammatory Bowel Disease
Yoonhwa Shin, Sunhee Han, Juhui Kwon, et al.
Nutrients (2023) Vol. 15, Iss. 20, pp. 4466-4466
Open Access | Times Cited: 68
Probiotic Consortia and Their Metabolites Ameliorate the Symptoms of Inflammatory Bowel Diseases in a Colitis Mouse Model
Limin Xu, Bingdong Liu, Liujing Huang, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 4
Open Access | Times Cited: 44
Uncovering the Beneficial Role of Limosilactobacillus fermentum E7 Exhibiting Antioxidant Activity in Ameliorating DSS-Induced Ulcerative Colitis in a Murine Model
Hongyan Zhang, Hailing Wang, Yue Li, et al.
Foods (2025) Vol. 14, Iss. 1, pp. 137-137
Open Access | Times Cited: 1
Leaky Gut Syndrome: An Interplay Between Nutrients and Dysbiosis
Ana Beatriz Marcari, Aline Dias Paiva, Claudio Roberto Simon, et al.
Current Nutrition Reports (2025) Vol. 14, Iss. 1
Closed Access | Times Cited: 1
Ferulic acid ameliorates ulcerative colitis in a rat model via the inhibition of two LPS-TLR4-NF-κB and NF-κB-INOS-NO signaling pathways and thus alleviating the inflammatory, oxidative and apoptotic conditions in the colon tissue
Maryam Ghasemi‐Dehnoo, Hossein Amini‐Khoei, Zahra Lorigooini, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 5, pp. 2587-2597
Closed Access | Times Cited: 21
Immunomodulatory Properties of Vitamin D in the Intestinal and Respiratory Systems
Fatheia N. Hamza, Sarah Daher, Hana Fakhoury, et al.
Nutrients (2023) Vol. 15, Iss. 7, pp. 1696-1696
Open Access | Times Cited: 20
Postbiotics: An alternative and innovative intervention for the therapy of inflammatory bowel disease
Kavita Kavita, Hari Om, Umesh Chand, et al.
Microbiological Research (2023) Vol. 279, pp. 127550-127550
Closed Access | Times Cited: 16
Probiotics for inflammatory bowel disease: Is there sufficient evidence?
Yueying Ma, Dandan Yang, Jin Huang, et al.
Open Life Sciences (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 7
Probiotic Consortia Protect the Intestine Against Radiation Injury by Improving Intestinal Epithelial Homeostasis
Liwei Xie, Haiyan Lu, Lin-Feng Tang, et al.
International Journal of Radiation Oncology*Biology*Physics (2024) Vol. 120, Iss. 1, pp. 189-204
Open Access | Times Cited: 6
Revealing the Potential Impacts of Nutraceuticals Formulated with Freeze-Dried Jabuticaba Peel and Limosilactobacillus fermentum Strains Candidates for Probiotic Use on Human Intestinal Microbiota
Jaielison Yandro Pereira da Silva, Heloísa Nascimento, Thatyane Mariano Rodrigues de Albuquerque, et al.
Probiotics and Antimicrobial Proteins (2023) Vol. 16, Iss. 5, pp. 1773-1789
Closed Access | Times Cited: 15
An insight into probiotic microorganisms
Archana Chaudhari, Shilpika Pandey, Mitesh Dwivedi
Elsevier eBooks (2025), pp. 17-50
Closed Access
Integrated microbiome, transcriptome and metabolome insight into the alleviating mechanisms of sheep milk in a DSS-induced colitis mouse model
Wenna Yao, Ruilin Du, Shuo Yan, et al.
Journal of Functional Foods (2025) Vol. 125, pp. 106691-106691
Closed Access
Polyphenols and inflammatory bowel disease: Natural products with therapeutic effects?
Mostafa Vaghari‐Tabari, Forough Alemi, Maryam Zokaei, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 64, Iss. 13, pp. 4155-4178
Closed Access | Times Cited: 20
Advances and optimization strategies in bacteriophage therapy for treating inflammatory bowel disease
Li Yang, Xiao-meng Li, Hao-yu Duan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Targeting gut microbiota dysbiosis in inflammatory bowel disease: a systematic review of current evidence
Ahmed Abdulrazak Ugas Farah, Pradipta Paul, Anfal Sher Khan, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Weizmannia coagulans BC99 Enhances Intestinal Barrier Function by Modulating Butyrate Formation to Alleviate Acute Alcohol Intoxication in Rats
C. Li, Shirui Zhai, Ming Duan, et al.
Nutrients (2024) Vol. 16, Iss. 23, pp. 4142-4142
Open Access | Times Cited: 3
Crohn’s Disease, Host–Microbiota Interactions, and Immunonutrition: Dietary Strategies Targeting Gut Microbiome as Novel Therapeutic Approaches
María Ángeles Núñez‐Sánchez, Silvia Melgar, KEITH O'DONOGHUE, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8361-8361
Open Access | Times Cited: 15
Designer probiotics: Opening the new horizon in diagnosis and prevention of human diseases
Nabendu Debnath, Pooja Yadav, Praveen Kumar Mehta, et al.
Biotechnology and Bioengineering (2023) Vol. 121, Iss. 1, pp. 100-117
Closed Access | Times Cited: 7
Tiron ameliorates acetic acid-induced colitis in rats: Role of TGF-β/EGFR/PI3K/NF-κB signaling pathway
Raghda N. El Mahdy, Manar A. Nader, Manar G. Helal, et al.
International Immunopharmacology (2024) Vol. 128, pp. 111587-111587
Closed Access | Times Cited: 2
From probiotic chassis to modification strategies, control and improvement of genetically engineered probiotics for inflammatory bowel disease
Yuewen Huang, Peng Shan, Rong Zeng, et al.
Microbiological Research (2024) Vol. 289, pp. 127928-127928
Closed Access | Times Cited: 2
Nutraceuticals and Diet Supplements in Crohn’s Disease: A General Overview of the Most Promising Approaches in the Clinic
Barbara De Conno, Marcella Pesce, Martina Chiurazzi, et al.
Foods (2022) Vol. 11, Iss. 7, pp. 1044-1044
Open Access | Times Cited: 9
Saccharomyces cerevisiae prevents postoperative recurrence of Crohn's disease modeled by ileocecal resection in HLA-B27 transgenic rats
Caroline Valibouze, Silvia Speca, Caroline Dubuquoy, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 5, pp. 851-866
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top